Drug class in one race

Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs for Atherosclerotic Cardiovascular Disease

2 tracked Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the Angiotensin II receptor / Calcium channel / HMG-CoA reductase page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.

2 Phase 3

Head-to-head evidence: CJ-30061 vs OLOMAX

The roster

← all Angiotensin II receptor / Calcium channel / HMG-CoA reductase drugs